Wells Fargo’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$749K Buy
64,674
+63,535
+5,578% +$736K ﹤0.01% 3532
2025
Q1
$9.94K Sell
1,139
-254
-18% -$2.22K ﹤0.01% 5419
2024
Q4
$20K Sell
1,393
-10,535
-88% -$151K ﹤0.01% 5273
2024
Q3
$269K Buy
11,928
+2,196
+23% +$49.6K ﹤0.01% 4002
2024
Q2
$189K Sell
9,732
-7,423
-43% -$144K ﹤0.01% 4194
2024
Q1
$644K Sell
17,155
-9,512
-36% -$357K ﹤0.01% 3391
2023
Q4
$1.49M Sell
26,667
-11,989
-31% -$671K ﹤0.01% 2841
2023
Q3
$1.59M Sell
38,656
-6,429
-14% -$265K ﹤0.01% 2753
2023
Q2
$2.52M Buy
45,085
+7,418
+20% +$414K ﹤0.01% 2574
2023
Q1
$2.1M Sell
37,667
-33,414
-47% -$1.86M ﹤0.01% 2645
2022
Q4
$2.59M Sell
71,081
-18,571
-21% -$677K ﹤0.01% 2439
2022
Q3
$2.55M Sell
89,652
-39,390
-31% -$1.12M ﹤0.01% 2398
2022
Q2
$5.84M Sell
129,042
-118,646
-48% -$5.37M ﹤0.01% 1882
2022
Q1
$18.8M Buy
247,688
+54,217
+28% +$4.12M ﹤0.01% 1294
2021
Q4
$28.8M Sell
193,471
-598,229
-76% -$89.1M 0.01% 1043
2021
Q3
$115M Buy
791,700
+23,753
+3% +$3.46M 0.03% 582
2021
Q2
$150M Buy
767,947
+8,574
+1% +$1.68M 0.03% 477
2021
Q1
$137M Buy
759,373
+706,619
+1,339% +$128M 0.03% 506
2020
Q4
$7.47M Buy
52,754
+19,293
+58% +$2.73M ﹤0.01% 2338
2020
Q3
$4.17M Sell
33,461
-230,034
-87% -$28.7M ﹤0.01% 2649
2020
Q2
$23.5M Sell
263,495
-511,359
-66% -$45.7M 0.01% 1250
2020
Q1
$48.3M Sell
774,854
-152,908
-16% -$9.53M 0.02% 772
2019
Q4
$70.7M Buy
927,762
+12,324
+1% +$940K 0.02% 749
2019
Q3
$46.1M Buy
+915,438
New +$46.1M 0.01% 954